Navigation Links
Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
Date:9/6/2009

th clinical factors-such as drug response, disease state, and treatment prognosis-and help physicians individualize treatment for each patient.

Further information on Elixior can be found at the Company's website: http://www.elixior.com. or further information, please contact:

    Anne Bruinvels, CEO
    Phone: +44(0)77-67-807-865
    E-mail: anne.bruinvels@elixior.com

'/>"/>
SOURCE Elixior Limited
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal
2. Laurence Barsh, DMD, Founder of Snoring Isn't Sexy, LLC Emphasizes Need to Evaluate and Treat Sleep Patients
3. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
4. Laurence I. Barsh, DMD, Founder of Snoring Isn't Sexy, to speak at Somnomed's First Annual Symposium
5. Randall Terry, Founder, Operation Rescue: Abortion, Healthcare, and Social Upheaval: Pro-life Leaders to Discuss Backlash -- Including Potential of Unwanted Violence
6. Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz
7. Founders of Running Skirts Inc. Set to Launch New Maternity Line
8. Founder and CEO of HealthTech, Molly Coye, MD, Assumes Leadership of CalRHIO
9. Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia
10. Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June
11. Medeguide Founder to Lead Online Healthcare Marketing Workshop at the Healthcare Travel Conference in Singapore

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...earchers from the University of Michigan determine...on Americans with hepatitis C virus (HCV) infectio.... Treatment rates appear to be declining, in part...nfected. If this disturbing trend continues, by 2... will be prevented by antiviral therapy. This stu...
(Date:11/23/2009)...Taxpayers may be on the hook for the high cost of ...according to a new study led by a University of Br...study, published today in the Archives of Interna...pidogrel, a top-selling drug also known by the tra...eart attack or stroke. The drug was selected to st...
(Date:11/23/2009)...open on-the-job interaction might ease the problem...ealthDay News) -- Men who bottle up their anger ov... hearts, a new Swedish study indicates. , Men w... over conflicts with a fellow worker or supervisor...tack or die of heart disease as those who vented t...
(Date:11/23/2009)..., WASHINGTON,Nov.23/PRNewswire-USNewswire/--TheAm...balchildren,spublishing,education,andmediacompany,...encecurriculumdesignedtosparkinterestinthefieldsof...xcitingcareeropportunitiesinhematology. ,, "Man...hoolaboutHemotheMagnificent,whichmadelearningabout...
(Date:11/23/2009)...e everybody, health care professionals enjoy a pay... financial incentives for health care performance ...ws that patient-care performance ratings for 25 me...tly following the launch of a statewide pay-for-pe... focused on doctors, productivity. , Reportin...
Breaking Medicine News(10 mins):Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3
...e after major tissue damage or surgical interventi...ver resection is an established therapeutic measur...ance to know which molecular events underly the re...ent of Gastroenterology and Hepatology of the Univ...
...e professional antigen presenting cells (APCs) tha...DCs are cells in the pathway of antigen capture an... to directly prime nave CD4+ and CD8+ T cells. Gas...c cancer, as it has spread to the lymph glands and...
...rgeted therapies the highlights of 2008 , ...ainst cancer gathered steam in 2008, as new drugs ...d advances were made in both disease prevention an...es" across the gamut of cancer prevention, screeni...
...A record-setting 5,000 delegates and corporate lea...remier scientific conference on topics relating to...seases and disabilities associated with the biolog...ogies convened the world,s most innovative physici...
...At the 16th Annual World Congress on Anti-Aging Me...in Las Vegas, Zannos Grekos, MD, director of Cardi... ( www.regenocyte.com ), addressed physicians from...aftment of stem cells into damaged organs and subs...
...utation faced higher odds of heart attack, death, ... News) -- A gene variation can make younger heart ..., death or other heart problems if they receive th...n are often used to prevent blood vessels from clo...
Other Medicine News:Health News:Molecular events involved in liver regeneration 2Health News:A new light on tumor immunotherapy for gastric cancer 2Health News:Cancer Medicine Advances on Many Fronts 2Health News:Cancer Medicine Advances on Many Fronts 3Health News:Cancer Medicine Advances on Many Fronts 4Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 2Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 3Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 4Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 5Health News: Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference 2Health News: Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference 3Health News:Gene Ups Risk for Those on Blood-Thinner Plavix 2Health News:Gene Ups Risk for Those on Blood-Thinner Plavix 3
(Date:11/23/2009)...23/PRNewswire/--ProteonTherapeutics,Inc.,hasinitia...-201,inend-stagerenaldisease(ESRD)patientsundergoi...studyrepresentsProteon,ssecondhumanclinicalstudyin...tionofaPhase1/2studyofPRT-201inESRDpatientsundergo...ierthisyear.Proteonalsoannouncestheappointmentofbo...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc.(...DavidC.U,PrichardhaveagreedtojointheAnesivaboardof...weenAnesivaandArcionTherapeutics.Completionoftheme...eatthepreviouslyannouncedAnesiva2009AnnualMeetingo...Tat400OysterPoint,Suite107A,SouthSanFrancisco,Cali...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--RaptorPharmaceuticalCorp...uncedresultsfromaPhase2bclinicaltrialofitspropriet...ne")inpatientswithnephropathiccystinosis("cystinos...,SanDiego("UCSD")GeneralClinicalResearchCenter,eva...acodynamicsofasingledoseofDRCysteamineinninecystin...
Breaking Medicine Technology:Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5PracticeMatch Announces Departure From Physician Recruiting 53526 1PracticeMatch Announces Departure From Physician Recruiting 53526 2Unilens Vision Inc Declares Regular Quarterly Cash Dividend of U S 240 09 Per Share 53524 1Unilens Vision Inc Declares Regular Quarterly Cash Dividend of U S 240 09 Per Share 53524 2Perrigo Announces FDA Approval for Generic Version of NASACORT 28R 29 AQ 53522 1Perrigo Announces FDA Approval for Generic Version of NASACORT 28R 29 AQ 53522 2Perrigo Announces FDA Approval for Generic Version of NASACORT 28R 29 AQ 53522 3
...e start of TRILOGY ACS clinical trial to study ... ACS patients, TOKYO and INDIANAPOLIS, June 23 D... Lilly and Company (NYSE: LLY ),said that the U.S...the,review period for the prasugrel new drug appli...vided during the review period. This three,month e...
...fers Tips for Benefits/HR Managers, DALLAS, June ...departments can play an important role in preventi... heart attacks, according to a,leading prevention ...disease prevention., Dr. Boyd Lyles, corporate me...,s not uncommon for heart attacks to strike indivi...
Other Medicine Technology:FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 2FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 3FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 4U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks 2U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks 3
...thropoietin (EPO) is the primary known naturally-o...he predicted molecular weight of human EPO is 18.2... of EPO has an estimated molecular mass of ~30.5 k...tructure, the EPO receptor bears some homology to ...
...citonin is synthesized in the parafollicular C-cel...ry granules. The major action of calcitonin is to ... osteoclast activity, resulting in decreased mobil...ost evident in conditions associated with high lev...
...an chorionic gonadotropin (hCG) is a two chain (al...ted by the chorionic tissue of the placenta and is...y. Produced by the trophoblastic epithelium of the...in the early stages of pregnancy. The primary util...
2600KL ProPlus® Digital Wheelchair Ramp Scales
Medicine Products: